EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction
Clinical trial NCT05584319 · UNKNOWN
Trial details
- NCT number
- NCT05584319
- Sponsor
- Zhijun Sun
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2024-10-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.